Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2000
10/26/2000CA2369969A1 Method of identifying toxic agents using differential gene expression
10/26/2000CA2369762A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes
10/26/2000CA2369755A1 Method for reducing a susceptibility to tumor formation induced by 3-deoxyglucosone and precursors thereof
10/26/2000CA2369342A1 Carbohydrate-modifying enzymes
10/26/2000CA2365523A1 Identification of sortase gene
10/26/2000CA2364209A1 49 human secreted proteins
10/26/2000CA2364191A1 Parasite antigens
10/26/2000CA2363984A1 Antibodies that recognize app cleaved by caspases and methods of use
10/26/2000CA2330231A1 Composition and method for modulating dendritic cell-t cell interaction
10/25/2000EP1046652A1 Method for quantitating denatured ldls
10/25/2000EP1046651A1 Composition and method for modulating dendritic cell-T interaction
10/25/2000EP1046421A2 Methods and reagents for very large scale immobilized polymer synthesis
10/25/2000EP1046038A1 Use of mass fingerprinting for identification of protein affinity ligands
10/25/2000EP1046036A1 Methods for obtaining probes of peptide function
10/25/2000EP1045926A2 Gene family with transformation modulating activity
10/25/2000EP1045914A1 Testis-specific human svph1-8 proteinase
10/25/2000EP1045913A2 Human protease molecules
10/25/2000EP1045908A2 Human urotensin ii
10/25/2000EP1045906A1 Apo-2 ligand
10/25/2000EP1045905A2 Il-17rh dna and polypeptides
10/25/2000EP1045904A1 Fatty acid transport proteins
10/25/2000EP1045900A2 Mammalian alpha helical protein-1
10/25/2000EP1045861A1 Antibody/receptor targeting moiety for enhanced delivery of armed ligand
10/25/2000EP1045859A1 NOVEL SURFACE PROTEIN OF $i(NEISSERIA MENINGITIDIS)
10/25/2000EP1045701A1 Methods of using human receptor protein 4-1bb
10/25/2000EP0750626B1 Corpuscles of stannius protein, stanniocalcin
10/25/2000EP0592549A4 Tissue specific imaging agents using internal image anti-idiotypic antibodies
10/25/2000CN1271389A Nucleic acid vaccines encoding G protein of respiratory syncytial virus
10/25/2000CN1271387A Mammalian cytokine: interleukin-B30 and related reagents
10/25/2000CN1271384A Method for influencing the P53 linkage in target genes
10/25/2000CN1271012A New human cation transfer related protein and its code sequence
10/25/2000CN1271011A New human phosphoric triesterase related protein and its code sequence
10/25/2000CN1271010A New human aromatic esterase protein and its code sequence
10/25/2000CN1271009A New human diacyl glyceropyrophosphate phosphatase protein and its code sequence
10/25/2000CN1271008A New human salt-resisting protein subunit protein and its code sequence
10/25/2000CN1271007A New human chitinase protein and its code sequence
10/25/2000CN1271006A New human proteinase subunit protein and its code sequence
10/25/2000CN1271005A New human cytochrome protein and its code sequence
10/25/2000CN1270839A Antigenic antibody vaccine of foot-and-mouth disease
10/25/2000CN1057774C 乙型肝炎疫苗 Hepatitis B Vaccine
10/24/2000US6136957 Antibodies which bind granulocyte-macrophane colony-stimulating factor receptor
10/24/2000US6136596 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
10/24/2000US6136595 Jak kinases and regulations of cytokine signal transduction
10/24/2000US6136583 Amidase
10/24/2000US6136581 Kinase genes and uses
10/24/2000US6136561 Methods of preparing carboxy-terminally truncated recombinant flavivirus envelope glycoproteins employing drosophila melanogaster expression systems
10/24/2000US6136556 TCTS response regulator
10/24/2000US6136528 Multiple sclerosis virus
10/24/2000US6136526 Use of human neutrophil lipocalin (HNL) as a diagnostic marker and anti-HNL-antibody preparation
10/24/2000US6136319 Method of treating viral diseases in animals
10/24/2000US6136313 Processes and intermediates for synthetic antibody derivatives
10/24/2000US6136312 Method for producing an IgM preparation for intravenous application
10/24/2000US6136311 Using monoclonal antibodies
10/24/2000US6136310 Recombinant anti-CD4 antibodies for human therapy
10/24/2000US6136309 Antibodies against the interferon (IFN) α/β receptor (IFNAR2) that preferentially block the activity of IFN-α
10/24/2000CA2005955C Synthetic hiv-like peptides, their compositions and uses
10/24/2000CA1341125C Dna encoding serotonin 1c (5ht1c) receptor, isolated 5ht1c receptor, mammalian cells expressing same and uses thereof
10/20/2000CA2271451A1 Variant c-terminal fragment of plasmodium falciparum msp-1
10/19/2000WO2000062071A1 Diagnostic and therapeutic use of antibodies against the urokinase receptor
10/19/2000WO2000062069A1 Method of detecting intimin-expressing microorganisms
10/19/2000WO2000062062A1 METHOD FOR QUANTIFYING TRANSFORMING GROWTH FACTOR-β1 AND METHOD FOR DETECTING CANCER BY USING SAME
10/19/2000WO2000061813A1 A second mammalian tankyrase
10/19/2000WO2000061794A1 Methods and compositions involving posttranslational modification of herpesvirus protein us1.5
10/19/2000WO2000061779A1 49 human secreted proteins
10/19/2000WO2000061774A2 Bone morphogenic proteins
10/19/2000WO2000061765A2 Lipoxygenase proteins and polynucleotides encoding the same
10/19/2000WO2000061758A1 Viral variants
10/19/2000WO2000061757A1 Tumor necrosis factor homologs and nucleic acids encoding the same
10/19/2000WO2000061756A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/19/2000WO2000061755A2 Secreted human proteins
10/19/2000WO2000061754A2 Human proteins and polynucleotides encoding them
10/19/2000WO2000061753A2 Compositions and methods for the treatment and diagnosis of breast cancer
10/19/2000WO2000061750A2 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS
10/19/2000WO2000061748A1 48 human secreted proteins
10/19/2000WO2000061746A1 13 transmembrane protein expressed in prostate cancer
10/19/2000WO2000061739A1 Method for controlling the activity of immunologically functional molecule
10/19/2000WO2000061728A2 Human elastase i
10/19/2000WO2000061724A2 Anti-bacterial vaccine compositions
10/19/2000WO2000061638A2 Detection of cancer and abnormal pregnancy using monoclonal antibodies specific for hcg isoforms
10/19/2000WO2000061637A1 Erythropoietin receptor antibodies
10/19/2000WO2000061636A2 Aberrantly glycosylated antibodies as marker for cancer
10/19/2000WO2000061635A2 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment
10/19/2000WO2000061629A1 49 human secreted proteins
10/19/2000WO2000061628A1 49 human secreted proteins
10/19/2000WO2000061627A1 49 human secreted proteins
10/19/2000WO2000061626A1 49 human secreted proteins
10/19/2000WO2000061625A1 48 human secreted proteins
10/19/2000WO2000061624A1 48 human secreted proteins
10/19/2000WO2000061623A1 62 human secreted proteins
10/19/2000WO2000061622A2 Genes associated with diseases of the kidney
10/19/2000WO2000061621A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061618A1 Fab-EPITOPE COMPLEX FROM THE HIV-1 CROSS-NEUTRALIZING MONOCLONAL ANTIBODY 2F5
10/19/2000WO2000061614A2 Uncoupling proteins
10/19/2000WO2000061612A2 Compounds and methods for therapy and diagnosis of lung cancer
10/19/2000WO2000061607A1 Separation of plasma components
10/19/2000WO2000061606A1 Novel human voltage-gated potassium channel
10/19/2000WO2000061596A1 50 human secreted proteins
10/19/2000WO2000061186A1 Use of anti-vegf antibody to enhance radiation in cancer therapy
10/19/2000WO2000061183A2 Verotoxin treatment of lymphomas
1 ... 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 ... 1494